Sumitomo Mitsui Trust Holdings, Inc. Sarepta Therapeutics, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,400 shares of SRPT stock, worth $178,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,400
Previous 4,381
68.04%
Holding current value
$178,094
Previous $567,000
61.02%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.31 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.15 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$550 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$527 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$485 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.1B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...